CEO and Co-Founder of OnSwipe
President of Stratos Product Development
President and COO, Tasktop Technologies
Medical device investor
Partner, ARCH Venture Partners
Managing Director, GlobalSmartEnergy
Prof. Dept. of Medicine/Hematology, Univ. of Washington
CTO, BuddyTV
|
|
Back in January I got an invitation out of the blue to give a 1-hour talk at the Palo Alto Research Center—the Xerox-owned lab better known as PARC. The invitation was completely open-ended. The full extent of PARC’s guidance was... Read more »
When Twitter landed in Boston earlier this year it didn’t mess around, spending around $200 million for two startups. And we’re starting to see more of the payoff for that expensive shopping trip.
Today, as part of its efforts to... Read more »
TubeMogul, a Bay Area startup that runs a platform distributing pay-per-view video ads across the Internet, announced earlier this month that it is opening an office in downtown Detroit. TubeMogul joins companies like Twitter in setting up shop in Dan Gilbert’s... Read more »
Much of the media world makes its money by pairing merchandise with television programs and movies. Now Web-streaming service Crunchyroll has updated its platform to improve the way it sells toys and other show-related products to fans.
Kun Gao, co-founder and... Read more »
What are the most powerful forces affecting innovation and the economy? That is one of the key questions facing the nation as we inch our way out of the economic mire.
Juan Enriquez may not have all the answers, but he... Read more »
David Karp’s wallet just got a lot fatter.
After a flurry of speculation over the weekend, Tumblr in New York is being acquired by Sunnyvale, CA-based Yahoo, in a deal announced early Monday at the previously reported price of $1.1 billion,... Read more »
I’m on the phone with Andy Miller, and I don’t know where to begin.
Ask him about working with Steve Jobs at Apple? About how Leap Motion may or may not be the next Apple? Or what about how that $348... Read more »
Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches, that ask you to attend a different meeting every day.... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
When Tel Aviv, Israel-based PrimeSense came out with its first depth-sensitive, near-infrared camera-on-a-chip in 2010, nobody could have predicted how many uses hardware makers would dream up for the technology within a few short years.
The first and most famous was... Read more »
Genentech made its name in cancer by creating targeted antibody drugs that zero in on tumor cells while mostly sparing healthy tissue. Now it’s seeking to compete in the next wave of cancer immunotherapies, which are designed to spark the immune... Read more »
Genentech has been searching for years to find a way to improve upon rituximab (Rituxan), which set a gold standard 15 years ago as part of the first generation of targeted antibody cancer drugs. Now it looks like Genentech... Read more »
For a minute I thought I was back in 2008, when Xconomy organized Boston’s first Battle of the Tech Bands. But no, this was 2013, and I was in San Francisco, at the Great American Music Hall (where the Grateful... Read more »
Electronic signatures company DocuSign is beefing up its real estate line with the acquisition of Cartavi and a tighter partnership with zipLogix, meant to enable transactions using any device.
DocuSign—founded in Seattle in 2004, but with its headquarters now in... Read more »
A prominent leader in the tech-startup community is moving on.
Walt Doyle, the longtime CEO of Where, which was acquired by PayPal in April 2011, has left the company as of today. Doyle served as general manager of PayPal Media... Read more »
There’s some more fuel for the online database arms race today: Boston-based Cloudant has secured a new $12 million investment round.
The money will bankroll Cloudant’s general growth, which includes a new office in San Francisco, complementing Cloudant’s previous footprint in Boston,... Read more »
After President Obama signed the JOBS Act more than a year ago, Ethan Senturia says he studied the provisions for crowdfunding startups under Title III, and came to the conclusion that it would be more trouble than it was worth.
Today... Read more »
Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. He spoke about what kinds of startups he likes to get involved in, the trend toward... Read more »
Henri Termeer could have easily faded away into obscurity a couple years ago. The biotech pioneer could have relaxed at his oceanside home in Maine, played a little golf. Or, if he wanted, he could have made loads of money at... Read more »
Head of global research and development at Life Technologies.
HP Senior Fellow, Hewlett-Packard Laboratories
Director, Neurobiotics Laboratory, University of Washington
Chair, Dept. of Cellular and Molecular Pharmacology, UCSF
Partner, ARCH Venture Partners
Professor, Stanford University
Partner, Morgenthaler Ventures
Partner, Morgenthaler Ventures
Professor of Biomolecular Engineering, UC Santa Cruz
Chairman and CEO, X PRIZE Foundation
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
